webleads-tracker

EFPIA

Working Hard Toward Better Transparency

Sunshine Act

The very best clinical practice does not take place in a vacuum. It requires input and expertise from many groups: clinicians; patient organisations; academics; healthcare organisations; and the manufacturers of new medicines and medical technology. Collaboration between my industry and these important customers results in three main benefits: 1. Making new medicines possible in the first place; 2. Providing vital health education needed to ensure that medicines are used appropriately; and 3. Capturing patient insights into current treatments and understanding unmet medical needs. The adoption of the EFPIA Healthcare Professional (HCP)/Healthcare Organisation (HCO) Disclosure Code will deliver long awaited financial …

Read More »

EFPIA : All Roads Lead to Consent

The European Pharmaceutical Industry Association (EFPIA) has preempted government sunshine regulations in Europe by providing a holistic approach to disclosing transfers of value between healthcare professionals (HCPs) and organizations (HCOs) for its 40+ members in 33+ countries. In 2016, EFPIA members will have to publicly disclose any transfer of value captured in 2015 on a per country basis. As a part of this process, EFPIA country member associations will have to ensure that standard EFPIA requirements conform to state or local data privacy regulations. To read the article by Véronique Monjardet

Read More »

EFPIA | Reflections on disclosure at ECC2015

Sunshine Act

As we pack up the stand after four fascinating days at the European Cancer Congress 2015, I have a little time to reflect on some of the conversations we have had on industry’s move to disclose publicly payments to health professionals. The first observation is that despite the first disclosures being scheduled for the second quarter of 2016, there are still many individuals in the medical community and even some in the industry that are not yet aware of this transformational step in the relationship between industry and the health professionals we work with. We had a number of conversations …

Read More »

UK HCPs back transparency over their pharma payments

sunsgine act

A poll of healthcare professionals (HCPs) in the UK has found that a majority believe payments made by pharma companies should be made public. The survey of more than 500 doctors, nurses, hospital specialists and pharmacists, commissioned by the Association of the British Pharmaceutical Industry (ABPI), indicated that 87% of respondents felt payments should be transparent. To read the article by Phil Taylor

Read More »

The EFPIA Disclosure Code: What needs to be disclosed?

Sunshine Act

Across Europe, by the end of June 2016, EFPIA member companies will disclose payments made to health professionals, such as sponsorship to attend meetings, speaker fees, consultancy and advisory boards. How this data will be disclosed will vary according to country; disclosures could be made on company websites or, where available, on a central platform for disclosure. In each case the type of activities subject to the provisions of the EFPIA disclosure code is the same. The EFPIA Disclosure code requires member companies to document and disclose the transfers of value it makes, directly or indirectly, to healthcare professionals (HCPs) …

Read More »

La publication en France et les projets EFPIA à la loupe

En juin dernier, Market iT, spécialiste des sciences de la vie, en partenariat avec le Think Tank Loi Bertrand et l’AFAR, l’Association Française des Affaires Réglementaires, a réalisé une enquête sur les conditions dans lesquelles les entreprises ont réalisé la première publication de leurs liens d’intérêts sur le site public unique, ainsi que sur l’état d’avancement de leurs projets EFPIA. Pour lire l’article de BMI SYSTEM

Read More »